Skip to main content
Premium Trial:

Request an Annual Quote

Assay Designs Acquires Stressgen Bioreagents

NEW YORK, July 12 (GenomeWeb News) - Assay Designs said today that it has acquired Stressgen Bioreagents for an undisclosed amount.

 

Assay Designs will take on Stressgen's employees, bringing the company's total number of workers to 85, Russell Hart, Assay Designs' co-founder and president said in a statement.

 

Based in Victoria, British Columbia, Stressgen markets develops and markets antibodies, proteins, and related kits to life sciences researchers. Ann Arbor, Mich.-based Assay Designs develops and manufactures immunoassay kits, luminescent reagents, antibodies, and proteins for the life sciences market.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.